Comparison

SPIRO vs Rheumatools John Libbey E.

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

SPIRO

This medical app assists healthcare professionals and students in interpreting spirometry tests. It provides diagnostic and treatment suggestions based on entered data and offers access to educational materials and respiratory health guidelines.

Highlights
  • Interpret spirometry tests
  • Diagnostic suggestions
  • Treatment suggestions
  • Access respiratory guidelines
  • Educational material
  • Patient follow-up tool
Read full description

Objective measurement of respiratory function is of primary importance in the assessment of chronic obstructive pulmonary diseases. However, the interpretation of respiratory function tests, especially spirometry tests, is considered suboptimal in primary care. A team from the Quebec Heart and Lung Institute affiliated with Laval University (IUCPQ-UL) developed an interactive mobile application called SPIRO© to facilitate the interpretation of spirometry tests. The SPIRO© app guides healthcare professionals and medical students in interpreting spirometry tests by entering basic data from a spirometry report (FEV1, FVC, FEV1/FVC). The software gives a diagnostic suggestion to the user based on pre-set intervals. In addition to being a resource for educational material (explanatory video, questionnaires, documents related to respiratory health guidelines), the SPIRO© application guides the user in applying the guidelines in respiratory health by providing the necessary references (scientific articles, respiratory health guidelines) to develop a treatment plan. The app allows: - Optimizing interpretation of spirometry; - Obtaining a diagnostic suggestion; - Obtaining a treatment suggestion according to respiratory guidelines; - Getting quick access to respiratory health guidelines; - Facilitating the work of health professionals; - Carrying out better follow-up of patients with chronic obstructive pulmonary disease (COPD) or asthma; - Obtaining continuing education through specific and relevant educational material. This tool was developed by the Chair in Knowledge Translation, Education and Prevention in Respiratory and Cardiovascular Health affiliated with Laval University in collaboration with the IUCPQ-UL.

About

Rheumatools John Libbey E.

Features
Read full description

Cette application médicale est à destination des professionnels de santé prenant en charge les maladies ostéo-articulaires ainsi que les maladies systémiques. L’objectif de cette application est d’aider le professionnel de santé dans sa pratique quotidienne. Plusieurs groupes d’outils sont à disposition : - Critères diagnostiques et de classifications des principaux rhumatismes inflammatoires, maladies systémiques, des pathologies microcristallines mais aussi des pathologies mécaniques. - Bilans Préthérapeutiques des antirhumatismaux biologiques et synthétiques ainsi que les biphosphonates. - Posologies des principales thérapeutiques (DMARDs, AINS, corticoïdes, antiostéoporotiques etc…) en rhumatologie en fonction des différentes pathologies. - Ordonnances de surveillance de traitements antirhumatismaux biologiques et synthétiques. - Les différents Scores d’activité des rhumatismes inflammatoires chroniques et des maladies systémiques ainsi que le score de FRAX et autres calculs de la calcémie corrigée, IMC ou surface corporelle. - Infiltrations : modalités de réalisation de gestes infiltratifs avec repères, technique et gestions des anticoagulants/antiagrégants. Aucune donnée relative à l’identité du patient n’est stockée dans l’application ni sur un serveur à distance. Cette application médicale a été coordonnée sur le plan scientifique par les : · Docteur Baptiste Coustet, service de rhumatologie, CHU Bichat-Claude Bernard, Paris · Professeur Philippe Dieudé, service de rhumatologie, CHU Bichat-Claude Bernard, Paris · Docteur Sébastien Ottaviani, service de rhumatologie, CHU Bichat-Claude Bernard, Paris. Rheumatools 2018 par John Libbey Eurotext Limited.

Screenshots

SPIRO4 screens
Rheumatools John Libbey E.4 screens

Verdict

The call

The clearest difference is price: Rheumatools John Libbey E. at Free against SPIRO's $3.99. SPIRO's advantage is iOS requirement (12.0 vs 16.0). On update cadence, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Rheumatools John Libbey E. is free to download; SPIRO costs $3.99 up front. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

SPIRO ships an update every 7 months, Rheumatools John Libbey E. every 8 months. The most recent releases landed on July 9, 2026 and September 12, 2026 respectively.

Scorecard2 real differences · 6 level
SPIRO versus Rheumatools John Libbey E.: the parameters behind the verdict, then further details
ParameterSPIRORheumatools John Libbey E.
Price$3.99Free — better
Positive reviews0.0% of reviews—
Update frequencyEvery 7 months — betterEvery 8 months
AdsNoNo
In-app purchasesNoNo
MonetizationPaid—
DevicesiPhone, iPod — betteriPhone
Requires iOS12.0 — better16.0
Further details — not scored
Size125 MB61 MB
Age rating12+17+
DeveloperUniversite LavalJohn Libbey Eurotext

In-app purchases

None

SPIRO

No in-app purchases

None

Rheumatools John Libbey E.

No in-app purchases

Questions

Is SPIRO free?
SPIRO costs $3.99, with no in-app purchases.
Is Rheumatools John Libbey E. free?
Rheumatools John Libbey E. is free to download, with no in-app purchases.
Do SPIRO or Rheumatools John Libbey E. have ads?
Neither SPIRO nor Rheumatools John Libbey E. shows ads.
Which is updated more often, SPIRO or Rheumatools John Libbey E.?
SPIRO ships an update every 7 months, and Rheumatools John Libbey E. every 8 months. Most recently, SPIRO was updated on July 9, 2026 and Rheumatools John Libbey E. on September 12, 2026.

Other comparisons